CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Contrast-enhanced intraoperative ultrasounddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01880554
NCT01880554N/ACompleted
CompareCT.gov

Clinical Utility of Contrast-enhanced Intraoperative Ultrasound in Surgery of Colorectal Liver Metastases. Phase II Clinical Trial.

Institut Bergonié·interventional·Posted Jun 19, 2013·Updated Sep 3, 2025

In Brief

A clinical study evaluating Contrast-enhanced intraoperative ultrasound for Liver Metastases From Colorectal Primary Cancer. Completed, enrolled 68 participants across 1 site.

Detailed Summary

Hypothesis: Use of contrast ultrasound showed interesting results, which can increase ultrasonography sensitivity performed during surgery in the evaluation of operable liver metastases. This study is a two-stage phase II multicenter study (Simon's two-stage).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Metastases From Colorectal Primary Cancer
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 19, 2013
Enrollment StartJun 1, 2011
Primary CompletionSep 1, 2016
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 13.0 years ago

Interventions

Contrast-enhanced intraoperative ultrasounddevice

Once the patient is included in the study, a staging procedure is performed in three stages before hepatic metastases treatment: Step # 1 preoperative (maximum 8 weeks before surgery Steps # 2 and # 3 intraoperative performed by the same surgeon in 2 stages